Lipid Transport - PowerPoint PPT Presentation

1 / 19
About This Presentation
Title:

Lipid Transport

Description:

Lipid Transport Lipoprotein Structure, Function, and Metabolism Clinical Case 8 y.o. girl Admitted for heart/lung transplantation Medical history Xanthomas at 2 yo MI ... – PowerPoint PPT presentation

Number of Views:630
Avg rating:3.0/5.0
Slides: 20
Provided by: cwuEduge1
Category:
Tags: lipid | transport

less

Transcript and Presenter's Notes

Title: Lipid Transport


1
Lipid Transport
  • Lipoprotein Structure, Function, and Metabolism

2
Clinical Case
  • 8 y.o. girl
  • Admitted for heart/lung transplantation
  • Medical history
  • Xanthomas at 2 yo
  • MI symptoms at 7 yo
  • TC1240mg/dl
  • TG350mg/dl
  • Diet statin cholestyramine
  • Mother TC 355, father TC310
  • Coronary artery bypass at 7 yo
  • 8 yo severe angina, second bypass
  • TC 1000mg/dl
  • Transplantation successful
  • TC260mg/dl, xanthomas regressing

3
Plasma LipoproteinsStructurefigure 19-1
  • LP core
  • Triglycerides
  • Cholesterol esters
  • LP surface
  • Phospholipids
  • Proteins
  • cholesterol

4
Plasma LipoproteinsClasses Functions
  • Chylomicrons
  • Synthesized in small intestine
  • Transport dietary lipids
  • 98 lipid, large sized, lowest density
  • Apo B-48
  • Receptor binding
  • Apo C-II
  • Lipoprotein lipase activator
  • Apo E
  • Remnant receptor binding

5
Chylomicron Metabolismfigure 19-3
  • Nascent chylomicron (B-48)
  • Mature chylomicron (apo C apo E)
  • Lipoprotein lipase
  • Chylomicron remnant
  • Apo C removed
  • Removed in liver

6
Plasma LipoproteinsClasses Functions
  • Very Low Density Lipoprotein (VLDL)
  • Synthesized in liver
  • Transport endogenous triglycerides
  • 90 lipid, 10 protein
  • Apo B-100
  • Receptor binding
  • Apo C-II
  • LPL activator
  • Apo E
  • Remnant receptor binding

7
Plasma LipoproteinsClasses Functions
  • Intermediate Density Lipoprotein (IDL)
  • Synthesized from VLDL during VLDL degradation
  • Triglyceride transport and precurser to LDL
  • Apo B-100
  • Receptor binding
  • Apo C-II
  • LPL activator
  • Apo E
  • Receptor binding

8
Plasma LipoproteinsClasses Functions
  • Low Density Lipoprotein (LDL)
  • Synthesized from IDL
  • Cholesterol transport
  • 78 lipid, 58 cholesterol CE
  • Apo B-100
  • Receptor binding

9
VLDL Metabolismfigure 19-4
  • Nascent VLDL (B-100) HDL (apo C E) VLDL
  • LPL hydrolyzes TG forming IDL
  • IDL loses apo C-II (reduces affinity for LPL)
  • 75 of IDL removed by liver
  • Apo E and Apo B mediated receptors
  • 25 of IDL converted to LDL by hepatic lipase
  • Loses apo E to HDL

10
Plasma LipoproteinsClasses Functions
  • High Density Lipoprotein (HDL)
  • Synthesized in liver and intestine
  • Reservoir of apoproteins
  • Reverse cholesterol transport
  • 52 protein, 48 lipid, 35 C CE
  • Apo A
  • Activates lecithin-cholesterol acyltransferase
    (LCAT)
  • Apo C
  • Activates LPL
  • Apo E
  • Remnant receptor binding

11
LDL Metabolism
  • LDL receptor-mediated endocytosis
  • LDL receptors on coated pits
  • Clathrin a protein polymer that stabilizes pit
  • Endocytosis
  • Loss of clathrin coating
  • uncoupling of receptor, returns to surface
  • Fusing of endosome with lysosome
  • Frees cholesterol amino acids

12
Coordinate Control of Cholesterol Uptake and
Synthesis
  • Increased uptake of LDL-cholesterol results in
  • inhibition of HMG-CoA reductase
  • reduced cholesterol synthesis
  • stimulation of acyl CoAcholesterol acyl
    transferase (ACAT)
  • increased cholesterol storage
  • TG C -gt DG CE
  • decreased synthesis of LDL-receptors
  • down-regulation
  • decreased LDL uptake

13
Heterogeneity of LDL-particles
  • Not all LDL-particles the same
  • Small dense LDL (diameter lt256A)
  • Large buoyant LDL (diameter gt256 A)
  • Lamarche B, St-Pierre AC, Ruel IL, et al. A
    prospective, population-based study of low
    density lipoprotein particle size as a risk
    factor for  Can J Cardiol 200117859-65.
  • 2057 men with hi LDL, 5 year follow-up
  • Those with elevated small dense LDL had RR of 2.2
    for IHD compared to men with elevated large
    buoyant LDL
  • Detection expensive
  • Treatment for lowering small dense LDL similar to
    lowering all LDL (diet, exercise, drugs)
  • Some drugs (niacin, fibrates) may be more
    effective at lowering small dense LDL.

14
LDL Particle Size and Apolipoprotein B Predict
Ischemic Heart Disease Quebec Cardiovascular
Study
6.2
(plt0.001)
Apo B
2.0
gt120 mg/dl
1.0
1.0
lt120 mg/dl
gt25.64
lt25.64
LDL Peak Particle Diameter (nm)
Lamarche B et al. Circulation 19979569-75.
15
HDL Metabolism Functions
  • Apoprotein exchange
  • provides apo C and apo E to/from VLDL and
    chylomicrons
  • Reverse cholesterol transport

16
Reverse cholesterol transportfigure 19-6
  • Uptake of cholesterol from peripheral tissues
    (binding by apo-A-I)
  • Esterification of HDL-C by LCAT
  • LCAT activated by apoA1
  • Transfer of CE to lipoprotein remnants (IDL and
    CR) by CETP
  • removal of CE-rich remnants by liver, converted
    to bile acids and excreted

17
Resolution of Clinical Case
  • Familial hypercholesterolemia (FH)
  • Family history
  • Early xanthomas and very high TC
  • Absence of LDL-receptors
  • Homozygous FH
  • Parent TC consistent with heterozygous FH
  • 1/500 Americans with heterozygous FH, treatable
    with diet/drugs
  • 1/106 with homozygous FH
  • Diet and drugs relatively ineffective
  • Liver has 70 of LDL-receptors
  • Combined liver/heart recommended because of
    advance CHD

18
(No Transcript)
19
Exam 2Monday, July 18
  • Lipid Transport
  • Chapter 19
  • MAAG chapter 54
  • Type 2 Diabetes and Insulin Resistance in Adipose
  • Effect on LPL causing hyperlipidemia
  • Signaling fault resulting in inappropriate
    lipolysis
  • Cholesterol Metabolism
  • Chapter 21
  • MAAG chapter 32
  • Format
  • Multiple choice questions
  • Short essay questions
Write a Comment
User Comments (0)
About PowerShow.com